How many patents does
Mapi Pharma have?
patents
224
families
34
granted
32
applications
192
EP
50
US
46
WO
37
CN
12
JP
2
RoW
77
Buy the report
The report contains ten-year analysis with the following sections
- patent filing analysis
- worldwide filing analysis
- patent family analysis
- application analysis
- granted analysis
- classification analysis
- citation analysis
contact us for pricing
- VAT will apply to UK companies
- EU companies must supply their VAT number
Check out our sample pages |
Find companies to compare
Many companies now available
companies
12,000+
patents
42 million
patent families
23 million
Search to find companies of interest
read summary of their published patent
the following tables are just extracts from the report
the company report contains more information
Mapi Pharma
Top ten assignees appearing on patents
2009 - 2018
| mapi pharma | 213 |
| mapi pharma holdings (cyprus) | 4 |
| stem cell medicine | 2 |
| mapi pharma hk | 2 |
| jiangsu nhwa pharmaceutical company | 2 |
| mapi phrarma | 1 |
| marpi pharma | 1 |
2009
Mapi Pharma
The top ten patent families are
|
Title of patent family (most common patent title) |
Family members |
Filing year |
|---|---|---|
| depot systems comprising glatiramer or a pharmacologically acceptable salt thereof | 21 | 2010 |
| polymorphs of darunavir | 16 | 2009 |
| intermediate compounds and processes for the preparation of quinoline derivatives such a… 🛈 | 14 | 2010 |
| intermediate compounds and process for the preparation of fingolimod | 14 | 2010 |
| process for the preparation of darunavir and darunavir intermediates | 13 | 2010 |
| intermediate compounds and processes for the preparation of tapentadol and related compo… 🛈 | 13 | 2009 |
| processes for the preparation of deferasirox, and deferasirox polymorphs | 13 | 2009 |
| process for the preparation of alogliptin | 13 | 2009 |
| preparation of benzofurans and use thereof as synthetic intermediates | 10 | 2010 |
| amorphous form of dolutegravir | 10 | 2011 |